DHSC

No-deal Brexit preparations wound down

DHSC advises no-deal preparations should cease.

Prescribing rates of high doses of vitamin D are at an all-time high for British children.

An export ban on colestyramine sachets and fluticasone propionate nasules came into effect on December 5.

The Department of Health and Social Care today reveals the second list of drug price concessions for October.

Four more medicines have been added to the list of those that cannot be parallel exported from the UK.

The government reveals plans to “increase the range of professions able to prescribe low-risk medicines."

The DHSC has ordered 400,000 extra doses of the adult flu vaccine for the 2019-20 flu season, it was announced yesterday.

Pharmacists have been granted powers to dispense an “alternative strength or pharmaceutical form” of fluoxetine.

The Department of Health and Social Care has announced the final list of drug price concessions for September.

Several HRT suppliers are putting “demand management processes” in place in the wake of acute stock shortages.

The Government will consider offering MMR vaccinations in “settings outside of a GP” to improve protection rates.

The DHSC has said the data it collects on medicines prices has improved since new regulations came into force.

PSNC is warning that payment for July prescriptions will reflect the new categorisation, not the information published in the July Drug Tariff.

The Government has launched a consultation on community pharmacy reimbursement reforms.

The new contractual framework will considerably expand clinical services from pharmacies over the next five years.

Category M reimbursement prices will increase by £15 million a month from August, the DHSC has said.

DHSC warns the main risk to the supply of medicines remains the likely bottlenecks at the short straits crossings.

Amendments to the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 have been laid before Parliament

Pharmacy minister Seema Kennedy said she is “alert” to the difficulties facing community pharmacy contractors.

The DHSC will reiterate its “great concern” to the suppliers of an epilepsy drug that has been affected by shortages, Seema Kennedy told the Commons